COVID first wave was just a road bump for ABT, JNJ, MDT, ISRG.
ABT investors have arguably benefitted from COVID insofar as ABT is the premiere COVID-diagnostics company. The stock is trading 25% higher than where it was at the end of January.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”